Type II diabetes treatment market value in Asia-Pacific to hit $10.5 billion by 2020: GBI Research
China will see the fastest expansion, with a CAGR of 11.1 per cent over the forecast period
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Home » Latest Updates » Page 415
Browsing Category
Latest Updates
Novartis collaborates with Intellia Therapeutics and Caribou Biosciences
To explore making medicines and drug discovery tools with CRISPR genome editing technology
Jubilant Life Sciences appoints Gurpartap Singh Sachdeva as CEO
Jubilant Life Sciences has appointed Gurpartap Singh Sachdeva has been appointed as the Chief Executive Officer, Jubilant Pharma,…
Jubilant Life Sciences, Lupin and Aurobindo Pharma receives US FDA approval for Valsartan tabs
Jubilant Life Sciences, Lupin and Aurobindo Pharma have received final approval from the US Food and Drug Administration (US FDA)…
Bone Therapeutics commences research on combined cell-matrix products
€1 million funding secured from the Walloon Region to investigate these innovative products for the treatment of large bone…
Lupin launches generic Diovan tabs
Is indicated for the treatment of hypertension and heart failure
Drug and Cosmetics (Amendment) Bill, 2015 to be introduced in Budget Session
Industry hails the move
Jubilant Life Sciences receives US FDA nod for Mycophenolate and MofetilRizatriptan tablets
Mycophenolate Mofetil is an immunosuppressant to help prevent organ rejection in transplants and Rizatriptan is used for the…
RPG Life Sciences appoints C T Renganathan as its MD
RPG Life Sciences has appointed CT Renganathan as its Managing Director and an Additional Director for a term of three years with…
Novartis completes divestment of animal health biz to Eli Lilly for $5.4 billion
The completion of this transaction will focus Novartis on its three leading businesses of global scale: innovative…